Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Target Price
The average target price of RCEL is 8.3 and suggests 88% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell